Dyrness Albert D. 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Dec 22, 2022
Insider Transaction Report
Form 4
Dyrness Albert D.
Director
Transactions
- Award
Common Stock
2022-12-14+3,770→ 30,893 total
Footnotes (2)
- [F1]On December 14, 2022, the Reporting Person was granted 3,770 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2024.
- [F2]Includes unvested RSUs.